Expansion into specialty segments Pernix Therapeutics targets underserved therapeutic areas such as CNS, neurology, and pain management. There is a potential sales opportunity to explore new specialty segments and expand the product portfolio to cater to unmet medical needs in those areas.

Partnership with Highbridge Capital Management The partnership with Highbridge Capital Management LLC presents a sales opportunity to leverage their resources and network for potential collaborations, funding, or strategic alliances that could drive business growth and market expansion.

Authorized generic product launch Launching an authorized generic version of Treximet paves the way for a sales opportunity to target a broader market segment seeking cost-effective alternatives. This product launch can help penetrate new customer segments and increase revenue streams.

Promotion and hiring of key personnel The promotions of Angus Smith to Senior Vice President, Chief Business Officer, and Principal Financial Officer demonstrate leadership stability and expertise. Leveraging the experience of key personnel in sales strategies and business development could enhance sales performance.

Refinancing transactions for financial stability The series of refinancing transactions indicate a strategic move towards financial stability. Leveraging this financial strength could present a sales opportunity to explore new investments, partnerships, or acquisitions that align with long-term growth objectives.